Ipamorelin + CJC-1295 (NO DAC) 10 mg

Ipamorelin + CJC-1295 (no DAC) 10mg is a combination research peptide formula studied for its role in pulsatile growth hormone–related signaling pathways. This stack brings together two peptides that act through complementary mechanisms: CJC-1295 (no DAC), a short-acting growth hormone releasing hormone (GHRH) analogue, and Ipamorelin, a selective ghrelin receptor agonist. Researchers are interested in this combination because it allows for the study of coordinated, pulse-based endocrine signaling, where natural timing and interaction between pathways can be observed. This compound remains investigational and is supplied strictly for laboratory research.

Key Research Attributes

• Combination research peptide stack
• Includes short-acting GHRH analogue (no DAC) and ghrelin receptor agonist
• Studied in pulsatile growth hormone and endocrine signaling models
• Lyophilized powder format
• Supplied strictly for laboratory research only

Why Researchers Are Interested

• Being studied for pulse-based growth hormone signaling pathways
• Researchers explore how dual-pathway activation influences endocrine timing
• May help investigate coordinated hormone release and regulatory patterns
• Often discussed in recovery, metabolic, and endocrine research models
• Has drawn attention as a balanced approach to studying natural signaling dynamics

This product is intended strictly for laboratory research purposes.
Not for human or veterinary use.